Mithra Pharmaceuticals S A : Publication of a transparency notification received from The Goldman Sachs Group Inc.

Liege, Belgium, 22 December 2023 - 17:45 CET - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces, in accordance with Article 14 of the Belgian Law of 02 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the "Transparency Law"), that it received on the 20 December 2023 a notification of transparency from The Goldman Sachs Group, Inc with registered offices at 1209 Orange Street, Wilmington, DE 19801, USA.

The Goldman Sachs Group, Inc. notified Mithra that it has dropped below the statutory notification-threshold of 3% of the 69,108,397 shares currently outstanding on 13 December 2023 to 2.99% (2 065 335 shares) of shares outstanding. Previously, The Goldman Sachs Group, Inc. held 3.41% (2 359 668 shares) of Mithra's outstanding securities.

The detailed transparency notifications are available on the Investors section of Mithra website. An updated overview of Mithra's shareholders structure will be included in the corporate governance charter of Mithra, which will be made available on its website.